Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway

Fructose 1,6-bisphosphate (FBP) is an endogenous intermediate of the glycolytic pathway. Exogenous administration of FBP has been shown to exert protective effects in a variety of ischemic injury models, which are attributed to its ability to sustain glycolysis and increase ATP production. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Veras, Flávio P., Peres, Raphael S., Saraiva, André L. L., Pinto, Larissa G., Louzada-Junior, Paulo, Cunha, Thiago M., Paschoal, Jonas A. R., Cunha, Fernando Q., Alves-Filho, José C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609967/
https://www.ncbi.nlm.nih.gov/pubmed/26478088
http://dx.doi.org/10.1038/srep15171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609967/
https://www.ncbi.nlm.nih.gov/pubmed/26478088
http://dx.doi.org/10.1038/srep15171

Ejemplares similares